Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Analergine
2. Antasten
3. Antazoline
4. Antazoline Hydrochloride
5. Antazoline Phosphate (1:1)
6. Antistine
7. Arithmin
8. Hydrochloride, Antazoline
9. Imidamine
10. Phenazoline
11. Phosphate, Antazoline
1. 154-68-7
2. Antazoline Phosphate [usp]
3. Antazoline Phosphate Salt
4. Antazoline Hpo
5. N-benzyl-4,5-dihydro-n-phenyl-1h-imidazole-2-methylamine Monophosphate
6. Nsc-755865
7. Antazoline Phosphate (usp)
8. Vpr5fph326
9. Mls000028623
10. 2-((n-benzylanilino)methyl)-2-imidazoline Phosphate (1:1)
11. Smr000058669
12. Benzyl-(4,5-dihydro-1h-imidazol-2-ylmethyl)-phenyl-amine . Hpo
13. N-benzyl-n-(4,5-dihydro-1h-imidazol-2-ylmethyl)aniline;phosphoric Acid
14. 1h-imidazole-2-methanamine, 4,5-dihydro-n-phenyl-n-(phenylmethyl)-, Phosphate (1:1)
15. 1h-imidazole-2-methanamine, 4,5-dihydro-n-phenyl-n-(phenylmethyl)-,phosphate (1:1)
16. Unii-vpr5fph326
17. Antazoline . Hpo
18. Antazoline H3po4
19. Einecs 205-831-4
20. Mfcd00054317
21. Opera_id_1677
22. Schembl23316
23. Mls001148180
24. 2-yl)methyl)aniline Phosphate
25. Spectrum1500126
26. Cid_158798
27. Chembl1200550
28. Hms500e05
29. Antazoline Phosphate [mi]
30. Dtxsid00165507
31. Hms1920e05
32. Hms2091k05
33. Hms2235h13
34. Hms3372h07
35. Pharmakon1600-01500126
36. Antazoline Phosphate [vandf]
37. Antazoline Phosphate [mart.]
38. Ccg-39133
39. Nsc755865
40. Antazoline Phosphate [usp-rs]
41. Antazoline Phosphate [who-dd]
42. Akos015963420
43. N-benzyl-n-(4,5-dihydro-1h-imidazol-2-ylmethyl)aniline,phosphoric Acid
44. Nsc 755865
45. Ncgc00094590-01
46. Ncgc00094590-02
47. Ncgc00094590-03
48. Ac-20134
49. Antazoline Phosphate [orange Book]
50. N-benzyl-n-((4,5-dihydro-1h-imidazol-
51. Antazoline Phosphate [usp Monograph]
52. Db-043231
53. Ft-0766726
54. 3-piperidinecarboxylicacidt-butylesterhcl
55. D02950
56. Vasocon-a Component Antazoline Phosphate
57. Antazoline Phosphate Component Of Vasocon-a
58. J-009133
59. Sr-01000000255-4
60. Q27291961
61. Antazoline Phosphate Salt, Analytical Standard, For Drug Analysis
62. N-benzyl-n-((4,5-dihydro-1h-imidazol-2-yl)methyl)aniline Phosphate
63. Antazoline Phosphate, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 363.3 g/mol |
---|---|
Molecular Formula | C17H22N3O4P |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 5 |
Exact Mass | 363.13479319 g/mol |
Monoisotopic Mass | 363.13479319 g/mol |
Topological Polar Surface Area | 105 Ų |
Heavy Atom Count | 25 |
Formal Charge | 0 |
Complexity | 364 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34330
Submission : 2020-01-01
Status : Active
Type : II
NDC Package Code : 42765-003
Start Marketing Date : 2019-10-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Antazoline Phosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Antazoline Phosphate, including repackagers and relabelers. The FDA regulates Antazoline Phosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Antazoline Phosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Antazoline Phosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Antazoline Phosphate supplier is an individual or a company that provides Antazoline Phosphate active pharmaceutical ingredient (API) or Antazoline Phosphate finished formulations upon request. The Antazoline Phosphate suppliers may include Antazoline Phosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Antazoline Phosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Antazoline Phosphate DMF (Drug Master File) is a document detailing the whole manufacturing process of Antazoline Phosphate active pharmaceutical ingredient (API) in detail. Different forms of Antazoline Phosphate DMFs exist exist since differing nations have different regulations, such as Antazoline Phosphate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Antazoline Phosphate DMF submitted to regulatory agencies in the US is known as a USDMF. Antazoline Phosphate USDMF includes data on Antazoline Phosphate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Antazoline Phosphate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Antazoline Phosphate suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Antazoline Phosphate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Antazoline Phosphate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Antazoline Phosphate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Antazoline Phosphate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Antazoline Phosphate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Antazoline Phosphate suppliers with NDC on PharmaCompass.
Antazoline Phosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Antazoline Phosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Antazoline Phosphate GMP manufacturer or Antazoline Phosphate GMP API supplier for your needs.
A Antazoline Phosphate CoA (Certificate of Analysis) is a formal document that attests to Antazoline Phosphate's compliance with Antazoline Phosphate specifications and serves as a tool for batch-level quality control.
Antazoline Phosphate CoA mostly includes findings from lab analyses of a specific batch. For each Antazoline Phosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Antazoline Phosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Antazoline Phosphate EP), Antazoline Phosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Antazoline Phosphate USP).
LOOKING FOR A SUPPLIER?